false000092661700009266172024-01-042024-01-04

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): January 4, 2024

Aspira Women’s Health Inc.

(Exact name of registrant as specified in its charter)





Delaware

001-34810

33-0595156

(State or other jurisdiction

(Commission

(IRS Employer

of incorporation)

File Number)

Identification No.)





12117 Bee Caves Road, Building III, Suite 100, Austin, Texas

78738

(Address of principal executive offices)

(Zip Code)

Registrant’s telephone number, including area code: (512) 519-0400



Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:



Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)



Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)





Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))





Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))




Securities registered pursuant to Section 12(b) of the Act:





Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, par value $0.001 per share

AWH

Nasdaq Capital Market



Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).



Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.





Item 7.01 Regulation FD Disclosure.

 

On January 4, 2024, Aspira Women's Health Inc. (the “Company”) presented an overview of the Company’s product pipeline status.  A copy of the Slide Deck is furnished as Exhibit 99.1 to this Current Report on Form 8-K filing.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

Exhibit No.

Description

99.1

Slide Deck Presented by Aspira Women’s Health Inc. On January 4, 2024

104

Cover Page Interactive Data File (the cover page XBRL tags are embedded within the Inline XBRL document)





SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.









ASPIRA WOMEN’S HEALTH INC.



Date: January 5, 2024

By:

/s/ Torsten Hombeck



Torsten Hombeck



Chief Financial Officer





 

 

 

 

 

Exhibit 99.1

 

A close-up of test tubes

Description automatically generated





A screenshot of a computer

Description automatically generated

 


 

A screenshot of a computer

Description automatically generated





A screenshot of a health investment

Description automatically generated


 

A diagram of a machine

Description automatically generated





A close-up of a diagram

Description automatically generated


 

A diagram of a patient testing

Description automatically generated





A diagram of a patient

Description automatically generated




 

A diagram of a biomarker

Description automatically generated





A white background with text

Description automatically generated




 

A screenshot of a medical procedure

Description automatically generated





A screenshot of a website

Description automatically generated




 

A screenshot of a computer

Description automatically generated





A screenshot of a medical information

Description automatically generated




 

A close-up of a white background

Description automatically generated





A screenshot of a computer

Description automatically generated




 

A screenshot of a medical test

Description automatically generated





A screenshot of a graph

Description automatically generated






 

A close-up of a document

Description automatically generated





A diagram of a development pathway

Description automatically generated






 

A white background with text

Description automatically generated





A screenshot of a medical diagnosis

Description automatically generated




 

A screenshot of a medical report

Description automatically generated





A screenshot of a medical information

Description automatically generated






 

A diagram of a graph

Description automatically generated with medium confidence





A screen shot of a computer

Description automatically generated




 

A screenshot of a medical test

Description automatically generated





A close-up of a graph

Description automatically generated




 

A diagram of a process

Description automatically generated





A white background with blue text

Description automatically generated




 

A screenshot of a web page

Description automatically generated





A screenshot of a computer

Description automatically generated




 

A group of green and blue rectangular shapes

Description automatically generated with medium confidence


v3.23.4
Document and Entity Information
Jan. 04, 2024
Document And Entity Information [Abstract]  
Document Type 8-K
Document Period End Date Jan. 04, 2024
Entity Registrant Name Aspira Women’s Health Inc.
Entity Incorporation, State or Country Code DE
Entity File Number 001-34810
Entity Tax Identification Number 33-0595156
Entity Address, Address Line One 12117 Bee Caves Road
Entity Address, Address Line Two Building III
Entity Address, Address Line Three Suite 100
Entity Address, City or Town Austin
Entity Address, State or Province TX
Entity Address, Postal Zip Code 78738
City Area Code 512
Local Phone Number 519-0400
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, par value $0.001 per share
Trading Symbol AWH
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
Entity Central Index Key 0000926617
Amendment Flag false

Aspira Womans Health (NASDAQ:AWH)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Aspira Womans Health Charts.
Aspira Womans Health (NASDAQ:AWH)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Aspira Womans Health Charts.